001     309617
005     20260204142438.0
024 7 _ |a 10.1038/s41392-025-02541-z
|2 doi
024 7 _ |a pmid:41629266
|2 pmid
024 7 _ |a 2095-9907
|2 ISSN
024 7 _ |a 2059-3635
|2 ISSN
037 _ _ |a DKFZ-2026-00267
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Li, Li
|0 P:(DE-He78)4a1b2b7196b7ebb1cbae04bc115edecc
|b 0
|e First author
245 _ _ |a Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosis.
260 _ _ |a London
|c 2026
|b Macmillan Publishers, part of Springer Nature
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1770211385_2119850
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:E055#EA:A411#LA:A411#LA:E055# / #NCTZFB26#
520 _ _ |a Radiotherapy remains a mainstay of cancer treatment. However, radiotherapy can also elicit acute and chronic adverse effects, including dermal inflammation and skin fibrosis. A comprehensive understanding of the underlying fibrotic processes remains elusive, and currently, no established treatment options exist. Canonical Wnt signaling has emerged as a significant player in fibrotic conditions. The Dickkopf (DKK) protein family comprises key modulators of Wnt signaling. To define the function of DKK3 in radiation-induced skin damage, we combined complementary in vivo and in vitro approaches, including a 3D human skin model, mice with cell-type-specific Dkk3 deletions, and irradiated human skin specimens. Our study revealed the pivotal role of DKK3 in regulating the response of the skin to radiation, with diminished DKK3 significantly mitigating radiation-induced skin damage. We found that radiation increases DKK3 expression in basal keratinocytes, leading to elevated ROS levels, TGF-β-mediated Wnt activation, epidermal hyperplasia, and subsequent skin fibrosis. Increased keratinocyte expression of DKK3 also drives macrophage polarization toward a CD163highCD206high profibrotic M2 phenotype, activating myofibroblasts and leading to fibrosis. Notably, DKK3 deficiency in keratinocytes markedly reduces radiation-induced dermal hyperplasia and fibrosis, identifying DKK3 as a key regulator of cutaneous radiation responses. These findings position DKK3 as a promising upstream modulator of TGF-β signaling for mitigating radiation-induced dermatitis and fibrosis, with potential relevance to other fibrotic diseases.
536 _ _ |a 319H - Addenda (POF4-319H)
|0 G:(DE-HGF)POF4-319H
|c POF4-319H
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a DKK3 protein, human
|2 NLM Chemicals
650 _ 7 |a Dkk3 protein, mouse
|2 NLM Chemicals
650 _ 7 |a Adaptor Proteins, Signal Transducing
|2 NLM Chemicals
650 _ 7 |a Intercellular Signaling Peptides and Proteins
|2 NLM Chemicals
650 _ 2 |a Keratinocytes: metabolism
|2 MeSH
650 _ 2 |a Keratinocytes: pathology
|2 MeSH
650 _ 2 |a Keratinocytes: radiation effects
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Wnt Signaling Pathway: genetics
|2 MeSH
650 _ 2 |a Wnt Signaling Pathway: radiation effects
|2 MeSH
650 _ 2 |a Fibrosis: genetics
|2 MeSH
650 _ 2 |a Fibrosis: pathology
|2 MeSH
650 _ 2 |a Mice
|2 MeSH
650 _ 2 |a Hyperplasia: genetics
|2 MeSH
650 _ 2 |a Hyperplasia: pathology
|2 MeSH
650 _ 2 |a Hyperplasia: metabolism
|2 MeSH
650 _ 2 |a Adaptor Proteins, Signal Transducing: genetics
|2 MeSH
650 _ 2 |a Adaptor Proteins, Signal Transducing: metabolism
|2 MeSH
650 _ 2 |a Skin: pathology
|2 MeSH
650 _ 2 |a Skin: radiation effects
|2 MeSH
650 _ 2 |a Skin: metabolism
|2 MeSH
650 _ 2 |a Intercellular Signaling Peptides and Proteins: genetics
|2 MeSH
650 _ 2 |a Radiodermatitis: genetics
|2 MeSH
650 _ 2 |a Radiodermatitis: pathology
|2 MeSH
650 _ 2 |a Radiodermatitis: metabolism
|2 MeSH
700 1 _ |a Lopez Perez, Ramon
|0 P:(DE-He78)c5a1a98649a7874de0def093eb136262
|b 1
|u dkfz
700 1 _ |a Shehzad, Khuram
|b 2
700 1 _ |a Jennemann, Richard
|0 P:(DE-He78)3caae9893e3b2704f7bb5a9646ef084d
|b 3
|u dkfz
700 1 _ |a Schmidt, Claudia
|0 P:(DE-He78)2a599a43bd0b5910c80edb288d8da3e5
|b 4
|u dkfz
700 1 _ |a Walle, Thomas
|0 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
|b 5
|u dkfz
700 1 _ |a Tietz-Dahlfuß, Alexandra
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Grimm, Elisabeth
|0 P:(DE-He78)e5f0e1cbcf3bdcd6a95dcd0fe056f704
|b 7
|u dkfz
700 1 _ |a Kraske, Joscha
|0 P:(DE-He78)7fb0841f5e88928308e29474e3170818
|b 8
|u dkfz
700 1 _ |a Häring, Peter
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Barayeu, Uladzimir
|0 P:(DE-He78)387d4f13f0c0f8a92fee635038e7d424
|b 10
700 1 _ |a Dick, Tobias P
|0 P:(DE-He78)7f55a0ed8b021080de00960cc73768fb
|b 11
|u dkfz
700 1 _ |a Ye, Luxi
|0 P:(DE-He78)96e7b84613a9b63b293faa3951427167
|b 12
700 1 _ |a Braun, Stephan A
|b 13
700 1 _ |a Hertl, Michael
|b 14
700 1 _ |a Worzfeld, Thomas
|b 15
700 1 _ |a Wiech, Thorsten
|b 16
700 1 _ |a Ji, Huihui
|b 17
700 1 _ |a Su, Jing
|b 18
700 1 _ |a Schneeweiss, Jonathan M
|b 19
700 1 _ |a Liu, Muzi
|0 P:(DE-He78)adccfec91f7014790171d2fe4d540131
|b 20
|u dkfz
700 1 _ |a Kommoss, Katharina
|0 P:(DE-He78)47a1ded1dddd8c84bd3a6e3f6e1e8769
|b 21
|u dkfz
700 1 _ |a Heikenwälder, Matthias
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Zou, Bingwen
|b 23
700 1 _ |a Mücklich, Sabrina
|b 24
700 1 _ |a Steinbrink, Kerstin
|b 25
700 1 _ |a Raker, Verena K
|0 0000-0001-7264-0371
|b 26
700 1 _ |a Wu, Wenjun
|0 P:(DE-He78)c9c21d72fdb58bb5185bb56e26e62899
|b 27
700 1 _ |a Noessner, Elfriede
|b 28
700 1 _ |a Gröne, Hermann-Josef
|b 29
700 1 _ |a Nelson, Peter J
|b 30
700 1 _ |a Sandhoff, Roger
|0 P:(DE-He78)a928ded2085c8911822370cad0b4a728
|b 31
|e Last author
|u dkfz
700 1 _ |a Huber, Peter
|0 P:(DE-He78)3291aaac20f3d603d96744c1f0890028
|b 32
|e Last author
|u dkfz
773 _ _ |a 10.1038/s41392-025-02541-z
|g Vol. 11, no. 1, p. 41
|0 PERI:(DE-600)2886872-9
|n 1
|p 41
|t Signal transduction and targeted therapy
|v 11
|y 2026
|x 2095-9907
909 C O |p VDB
|o oai:inrepo02.dkfz.de:309617
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)4a1b2b7196b7ebb1cbae04bc115edecc
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)c5a1a98649a7874de0def093eb136262
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)3caae9893e3b2704f7bb5a9646ef084d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)2a599a43bd0b5910c80edb288d8da3e5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)e5f0e1cbcf3bdcd6a95dcd0fe056f704
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)7fb0841f5e88928308e29474e3170818
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)387d4f13f0c0f8a92fee635038e7d424
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)7f55a0ed8b021080de00960cc73768fb
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)96e7b84613a9b63b293faa3951427167
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)adccfec91f7014790171d2fe4d540131
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)47a1ded1dddd8c84bd3a6e3f6e1e8769
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)c9c21d72fdb58bb5185bb56e26e62899
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 31
|6 P:(DE-He78)a928ded2085c8911822370cad0b4a728
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)3291aaac20f3d603d96744c1f0890028
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-319H
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Addenda
|x 0
914 1 _ |y 2026
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-04-10T15:44:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-04-10T15:44:53Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2024-04-10T15:44:53Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-04-10T15:44:53Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b SIGNAL TRANSDUCT TAR : 2022
|d 2024-12-17
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b SIGNAL TRANSDUCT TAR : 2022
|d 2024-12-17
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-17
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-17
920 2 _ |0 I:(DE-He78)A411-20160331
|k A411
|l Lipid-Pathobiochemie
|x 0
920 2 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Molekulare Radioonkologie
|x 1
920 1 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Molekulare Radioonkologie
|x 0
920 1 _ |0 I:(DE-He78)A411-20160331
|k A411
|l Lipid-Pathobiochemie
|x 1
920 1 _ |0 I:(DE-He78)W250-20160331
|k W250
|l Präklinische und Translationale Pathologie Core Facility
|x 2
920 1 _ |0 I:(DE-He78)E040-20160331
|k E040
|l E040 Med. Physik in der Strahlentherapie
|x 3
920 1 _ |0 I:(DE-He78)A160-20160331
|k A160
|l A160 Redoxregulation
|x 4
920 1 _ |0 I:(DE-He78)D440-20160331
|k D440
|l Chronische Entzündung und Krebs
|x 5
920 1 _ |0 I:(DE-He78)HD02-20160331
|k HD02
|l Koordinierungsstelle NCT Heidelberg
|x 6
920 0 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Molekulare Radioonkologie
|x 0
920 0 _ |0 I:(DE-He78)A411-20160331
|k A411
|l Lipid-Pathobiochemie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E055-20160331
980 _ _ |a I:(DE-He78)A411-20160331
980 _ _ |a I:(DE-He78)W250-20160331
980 _ _ |a I:(DE-He78)E040-20160331
980 _ _ |a I:(DE-He78)A160-20160331
980 _ _ |a I:(DE-He78)D440-20160331
980 _ _ |a I:(DE-He78)HD02-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21